2026 Summer Intern Clinical Supply Chain at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

InternshipJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Currently enrolled in a Bachelor’s Degree program with a minimum GPA 3.0
Desired backgrounds include Supply Chain Management, Operations Management, Pharmaceutical Business
Must be enrolled in school the semester prior to the internship
Must have strong analytical, project management skills
Must have excellent written and verbal communication skills
Must be highly organized and able to work in teams in a matrixed environment
All candidates must be authorized to work in the US both at the time of hire and for the duration of their employment (no immigration or visa sponsorship available)

Responsibilities

Support development and implementation of Supply Chain strategies at global network level or individual SKU level
Learn, develop and leverage analytics tools to inform and recommend methods for continuous improvement
Develop, execute innovation projects
Develop/refine IT tools to enable data visibility and minimize manual tasks
Perform demand & supply planning scenario, risk, and sensitivity analyses by brand and portfolio in support of planning and ad-hoc reviews
Provide project management support to teams
Monitor and maintain material master data accuracy

Skills

Lean Six Sigma

Project Management

Value Stream Mapping

RACI

SIPOC

SAP

Tableau

Product Lifecycle Management

Program Management

Communications

Change Management

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free